Timing of levothyroxine administration affects serum thyrotropin concentration
Open accessAbstract
CONTEXT: Patients treated with levothyroxine typically ingest it in a fasting state to prevent food impairing its absorption. The serum thyrotropin concentration is the therapeutic index of levothyroxine action. OBJECTIVE: The study objective was to determine the effect of the timing of levothyroxine administration in relationship to food on serum thyrotropin levels. DESIGN: Participants were randomized to one of six sequences, each consisting of three 8-wk regimens in a three-period crossover design. These regimens were in a fasting state, at bedtime, and with breakfast. The concentrations of TSH, free T(4), and total T(3) during each of the three timing regimens were documented. The primary outcome was the difference between serum TSH concentrations under fasting conditions compared with concentrations during the other 8-wk regimens. SETTING: The study was conducted in an academic medical center. PARTICIPANTS: Study participants were receiving levothyroxine for treatment of hypothyroidism or thyroid cancer. RESULTS: Sixty-five patients completed the study. The mean thyrotropin concentration was 1.06 +/- 1.23 mIU/liter when levothyroxine was administered in the fasting state. When levothyroxine was taken with breakfast, the serum thyrotropin concentration was significantly higher (2.93 +/- 3.29 mIU/liter). When levothyroxine was taken at bedtime, the serum TSH concentration was also significantly higher (2.19 +/- 2.66 mIU/liter). CONCLUSION: Nonfasting regimens of levothyroxine administration are associated with higher and more variable serum TSH concentrations. If a specific serum TSH goal is desired, thereby avoiding iatrogenic subclinical thyroid disease, then fasting ingestion of levothyroxine ensures that TSH concentrations remain within the narrowest target range.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a study comparing three timing regimens in 65 patients with primary hypothyroidism, with-breakfast dosing resulted in highest and most variable TSH levels, one hour before breakfast was associated with lowest and least variable TSH, and bedtime LT4 produced values and variability in-between.
“In a study which compared three timing regimens in 65 patients with primary hypothyroidism, a with-breakfast dosing resulted in the highest and most variable TSH levels, while a regimen of LT4 being administered an hour before breakfast was associated with the lowest and least variable TSH; the bedtime LT4 regimen produced values and variability that was in-between the other two dosing regimens (4”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [41]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredTwo recent cross-over studies had different findings, with lowest serum TSH values seen either 1 hour before breakfast or at bedtime.
“Two recent cross-over studies had different findings with the lowest serum TSH values being seen either 1 hour before breakfast or at bedtime (128,129).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [128]
In one cross-over study, mean TSH values were 1.06, 2.93, and 2.19 mIU/L for LT4 taken at least 1 hour before breakfast, with breakfast, or at bedtime, respectively.
“The mean TSH values seen with these different conditions were 1.06, 2.93, and 2.19 mIU/L respectively (128).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [128]
Four of six studies examining timing of LT4 administration showed that timing influences serum TSH values in hypothyroid patients receiving treatment.
“Four studies (121,126,128,129), out of the six studies examining this issue (121,128-131), have shown that the timing of LT4 administration influences the serum TSH values of hypothyroid patients receiving treatment.”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [128]
Coingestion with breakfast or coffee can reduce and delay LT4 absorption.
“Coingestion with breakfast or coffee can reduce and delay absorption (21, 22).”
From Levothyroxine: conventional and novel drug delivery formulations. (2023) · cites this paper as [21]
Bach-Huynh et al. three-period crossover study of 65 LT4-treated stable hypothyroid patients found non-fasting LT4 administration was associated with higher and more variable serum TSH concentrations.
“Bach-Huynh et al. three-period crossover study of 65 LT4-treated stable hypothyroid patients found that non-fasting LT4 administration was associated with higher and more variable serum TSH concentrations [ 33 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · see citing works
Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
Jonklaas, J., Sarlis, N. J., Litofsky, D. R., Ain, K. B., Bigos, S. T., Brierley, J. D., Cooper, D. S., Haugen, B. R., Ladenson, P. W., Magner, J. A., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.1229 · Cited by 693 · see citing works
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686 · see citing works
Fish, L. H., Schwartz, H. L., Cavanaugh, J., Steffes, M. W., Bantle, J. P., & Oppenheimer, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161302 · Cited by 353 · see citing works
Thyroxine in Goiter, <i>Helicobacter pylori</i> Infection, and Chronic Gastritis
Centanni, M., Gargano, L., Canettieri, G., Viceconti, N., Franchi, A., Fave, G. D., & Annibale, B. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043903 · Cited by 329 · see citing works
Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism
Campbell, N. R. C., Hasinoff, B. B., Stalts, H., Rao, B., & Wong, N. C. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1010 · Cited by 231 · see citing works
Effect of calcium carbonate on the absorption of levothyroxine
Singh, N. (2000) · JAMA · doi:10.1001/jama.283.21.2822 · Cited by 219 · see citing works
CARR, D., MCLEOD, D. T., PARRY, G., & THORNES, H. M. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb01219.x · Cited by 210 · see citing works
Altered intestinal absorption of L-thyroxine caused by coffee
Benvenga, S., Bartolone, L., Pappalardo, M. A., Russo, A., Lapa, D., Giorgianni, G., Saraceno, G., & Trimarchi, F. (2008) · Thyroid · doi:10.1089/thy.2007.0222 · Cited by 191 · see citing works
Delayed Intestinal Absorption of Levothyroxine
BENVENGA, S., BARTOLONE, L., SQUADRITO, S., GIUDICE, F. L., & TRIMARCHI, F. (1995) · Thyroid · doi:10.1089/thy.1995.5.249 · Cited by 156 · see citing works
Aspects of the absorption of oral L-thyroxine in normal man
Wenzel, K. W., & Kirschsieper, H. E. (1977) · Metabolism · doi:10.1016/0026-0495(77)90121-4 · Cited by 151 · see citing works
Localization of human thyroxine absorption
HAYS, M. T. (1991) · Thyroid · doi:10.1089/thy.1991.1.241 · Cited by 138 · see citing works
Liel, Y., Harman-Boehm, I., & Shany, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636317 · Cited by 129 · see citing works
Use Of Soy Protein Supplement And Resultant Need For Increased Dose Of Levothyroxine
Bell, D. S. H., & Montanya, E. (2001) · Endocrine Practice · doi:10.4158/ep.7.3.193 · Cited by 124 · see citing works
Sachmechi, I., Reich, D. M., Aninyei, M., Wibowo, F., Gupta, G., & Kim, P. J. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.345 · Cited by 112 · see citing works
Sucralfate causes malabsorption of L-thyroxine
Sherman, S. I., Tielens, E. T., & Ladenson, P. W. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90093-0 · Cited by 105 · see citing works
Pseudomalabsorption of levothyroxine
Ain, K. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470150090036 · Cited by 100 · see citing works
Bolk, N., Visser, T. J., Kalsbeek, A., van Domburg, R. T., & Berghout, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02681.x · Cited by 96 · see citing works
Checchi, S., Montanaro, A., Pasqui, L., Ciuoli, C., De Palo, V., Chiappetta, M. C., & Pacini, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1544 · Cited by 89 · see citing works
Are Bioequivalence Studies of Levothyroxine Sodium Formulations in Euthyroid Volunteers Reliable?
Blakesley, V., Awni, W., Locke, C., Ludden, T., Granneman, G. R., & Braverman, L. E. (2004) · Thyroid · doi:10.1089/105072504773297867 · Cited by 85 · see citing works
New medications which decrease levothyroxine absorption
John-Kalarickal, J., Pearlman, G., & Carlson, H. E. (2007) · Thyroid · doi:10.1089/thy.2007.0060 · Cited by 82 · see citing works
Raloxifene Causing Malabsorption of Levothyroxine
Siraj, E. S., Gupta, M. K., & Reddy, S. S. K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1367 · Cited by 76 · see citing works
Effects of grapefruit juice on the absorption of levothyroxine
Lilja, J. J., Laitinen, K., & Neuvonen, P. J. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02433.x · Cited by 74 · see citing works
Lactose intolerance revealed by severe resistance to treatment with levothyroxine
Muñoz-Torres, M., Varsavsky, M., & Alonso, G. (2006) · Thyroid · doi:10.1089/thy.2006.16.1171 · Cited by 54 · see citing works
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40 · see citing works
Levothyroxine dosage and the limitations of current bioequivalence standards
Hennessey, J. V. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0273 · Cited by 28 · see citing works
Parenteral thyroxine administration
Hays, M. T. (2007) · Thyroid · doi:10.1089/thy.2006.0283 · Cited by 27 · see citing works
Berg, J. A., & Mayor, G. H. (1992) · The Journal of Clinical Pharmacology · doi:10.1177/009127009203201213 · Cited by 22 · see citing works
Wenzel, K. W. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1068634 · Cited by 14 · see citing works
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Lamson MJ, Pamplin CL, Rolleri RL, Klein I 2004 Quantitation of a substantial reduction in levothyroxine (T4) absorption by food. Thyroid 14:876 [Google Scholar]
- Wenzel KW 1986 [Optimization of levothyroxine treatment. Dosage dependence on the existing parenchymal mass, age, body weight and fasting intake]. Dtsch Med Wochenschr 111:1356–1362 [DOI] [PubMed] [Google Scholar]
- Elliott DP 2001 Effect of levothyroxine administration time on serum TSH in elderly patients. Ann Pharmacother 35:529–532 [DOI] [PubMed] [Google Scholar]
Cited by
Sorted by citations
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928 · see citing works
“Two recent cross-over studies had different findings with the lowest serum TSH values being seen either 1 hour before breakfast or at bedtime (128,129).”
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567 · see citing works
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053 · see citing works
2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877 · see citing works
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259 · see citing works
Hypothyroidism: etiology, diagnosis, and management
Almandoz, J. P., & Gharib, H. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.005 · Cited by 216 · see citing works
Treatment for primary hypothyroidism: current approaches and future possibilities
Vaidya, B., Chakera, A. J., & Pearce, S. H. S. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s12894 · Cited by 202 · see citing works
Gastrointestinal malabsorption of thyroxine
Virili, C., Antonelli, A., Santaguida, M. G., Benvenga, S., & Centanni, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00168 · Cited by 164 · see citing works
Clinical practice guidelines for the management of hypothyroidism
Brenta, G., Vaisman, M., Sgarbi, J. A., Bergoglio, L., de Andrada, N. C., Bravo, P. P., Orlandi, A. M., & Graf, H. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000400003 · Cited by 161 · see citing works
Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review
Skelin, M., Lucijanić, T., Amidžić Klarić, D., Rešić, A., Bakula, M., Liberati-Čizmek, A.-M., Gharib, H., & Rahelić, D. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.01.005 · Cited by 133 · see citing works
Effects of Evening vs Morning Levothyroxine Intake: A Randomized Double-blind Crossover Trial
Bolk, N. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.436 · Cited by 128 · see citing works
Hashimoto’s Thyroiditis and Autoimmune Gastritis
Cellini, M., Santaguida, M. G., Virili, C., Capriello, S., Brusca, N., Gargano, L., & Centanni, M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00092 · Cited by 120 · see citing works
Hypothyroidism and Thyroiditis
Brent, G. A., & Davies, T. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00013-4 · Cited by 115 · see citing works
Atypical celiac disease as cause of increased need for thyroxine: a systematic study
Virili, C., Bassotti, G., Santaguida, M. G., Iuorio, R., Del Duca, S. C., Mercuri, V., Picarelli, A., Gargiulo, P., Gargano, L., & Centanni, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1851 · Cited by 114 · see citing works
Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report
Centanni, M., Benvenga, S., & Sachmechi, I. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0706-y · Cited by 113 · see citing works
“Review the thyroxine ingestion history The most efficient way to take levothyroxine—and the most reproducible—is to ingest the tablets on an empty stomach and avoid other medications or food for 30–60 min (preferably 60) thereafter [4, 5, 48].”
BackgroundThyroid hormone therapy for hypothyroidism
Biondi, B., & Cooper, D. S. (2019) · Endocrine · doi:10.1007/s12020-019-02023-7 · Cited by 110 · see citing works
Vita, R., Saraceno, G., Trimarchi, F., & Benvenga, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2684 · Cited by 99 · see citing works
Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient’s Lifetime
Duntas, L. H., & Jonklaas, J. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01078-2 · Cited by 94 · see citing works
The administration of l -thyroxine as soft gel capsule or liquid solution
Vita, R., Fallahi, P., Antonelli, A., & Benvenga, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.918101 · Cited by 93 · see citing works
Vita, R., Saraceno, G., Trimarchi, F., & Benvenga, S. (2013) · Endocrine · doi:10.1007/s12020-012-9772-2 · Cited by 91 · see citing works
Levothyroxine Replacement Doses Are Affected by Gender and Weight, But Not Age
Devdhar, M., Drooger, R., Pehlivanova, M., Singh, G., & Jonklaas, J. (2011) · Thyroid · doi:10.1089/thy.2011.0029 · Cited by 90 · see citing works
Self-citationOptimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89 · see citing works
Levothyroxine interactions with food and dietary supplements – a systematic review
Wiesner, A., Gajewska, D., & Paśko, P. (2021) · Pharmaceuticals · doi:10.3390/ph14030206 · Cited by 85 · see citing works
“Similar results were obtained in many other studies [26–30].”
ResultCappelli, C., Pirola, I., Daffini, L., Formenti, A., Iacobello, C., Cristiano, A., Gandossi, E., Agabiti Rosei, E., & Castellano, M. (2016) · Thyroid · doi:10.1089/thy.2015.0422 · Cited by 80 · see citing works
Cohen, B. M., Sommer, B. R., & Vuckovic, A. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17080949 · Cited by 79 · see citing works
When thyroid hormone replacement is ineffective?
Benvenga, S. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000003 · Cited by 74 · see citing works
Thyroxine replacement: a clinical endocrinologist’s viewpoint
Eligar, V, Taylor, P., Okosieme, O., Leese, G., & Dayan, C. (2016) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563216642255 · Cited by 72 · see citing works
Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine
Cellini, M., Santaguida, M. G., Gatto, I., Virili, C., Del Duca, S. C., Brusca, N., Capriello, S., Gargano, L., & Centanni, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1217 · Cited by 72 · see citing works
Sex and Age Differences in Levothyroxine Dosage Requirement
Jonklaas, J. (2010) · Endocrine Practice · doi:10.4158/ep09257.or · Cited by 72 · see citing works
A. Irving, S., Vadiveloo, T., & Leese, G. P. (2015) · Clinical Endocrinology · doi:10.1111/cen.12559 · Cited by 69 · see citing works
Thyroxine softgel capsule in patients with gastric-related T4 malabsorption
Santaguida, M. G., Virili, C., Duca, S. C. D., Cellini, M., Gatto, I., Brusca, N., De Vito, C., Gargano, L., & Centanni, M. (2015) · Endocrine · doi:10.1007/s12020-014-0476-7 · Cited by 68 · see citing works
The emergence of levothyroxine as a treatment for hypothyroidism
Hennessey, J. V. (2017) · Endocrine · doi:10.1007/s12020-016-1199-8 · Cited by 66 · see citing works
Serum Thyrotropin Levels Following Levothyroxine Administration at Breakfast
Perez, C. L. S., Araki, F. S., Graf, H., & de Carvalho, G. A. (2013) · Thyroid · doi:10.1089/thy.2012.0435 · Cited by 63 · see citing works
Levothyroxine: conventional and novel drug delivery formulations.
Liu, H., Li, W., Zhang, W., Sun, S., & Chen, C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac030 · Cited by 63 · see citing works
Vita, R., & Benvenga, S. (2014) · Endocrine Practice · doi:10.4158/ep13316.cr · Cited by 60 · see citing works
Asik, M., Gunes, F., Binnetoglu, E., Eroglu, M., Bozkurt, N., Sen, H., Akbal, E., Bakar, C., Beyazit, Y., & Ukinc, K. (2014) · Endocrine · doi:10.1007/s12020-013-0065-1 · Cited by 58 · see citing works
Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches
Centanni, M. (2013) · Endocrine · doi:10.1007/s12020-012-9814-9 · Cited by 56 · see citing works
Caron, P., Grunenwald, S., Persani, L., Borson-Chazot, F., Leroy, R., & Duntas, L. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09691-9 · Cited by 53 · see citing works
Assay of Thyroid Hormones and Related Substances
Spencer, C. A. (2013) · Europe PMC (PubMed Central) · Cited by 53 · see citing works
Rajput, R., Chatterjee, S., & Rajput, M. (2011) · Journal of Thyroid Research · doi:10.4061/2011/505239 · Cited by 52 · see citing works
Levothyroxine therapy in gastric malabsorptive disorders
Virili, C., Brusca, N., Capriello, S., & Centanni, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.621616 · Cited by 52 · see citing works
Fierabracci, P., Martinelli, S., Tamberi, A., Piaggi, P., Basolo, A., Pelosini, C., Ricco, I., Magno, S., Querci, G., Ceccarini, G., et al. (2016) · Thyroid · doi:10.1089/thy.2015.0473 · Cited by 51 · see citing works
Fallahi, P., Ferrari, S. M., Ruffilli, I., Ragusa, F., Biricotti, M., Materazzi, G., Miccoli, P., & Antonelli, A. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1227782 · Cited by 48 · see citing works
Brancato, D., Scorsone, A., Saura, G., Ferrara, L., Di Noto, A., Aiello, V., Fleres, M., & Provenzano, V. (2014) · Endocrine Practice · doi:10.4158/ep13418.or · Cited by 44 · see citing works
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism- Correspondence.
Stott, D. J., Rodondi, N., & Bauer, D. C. (2017) · Bern Open Repository and Information System (University of Bern) · doi:10.7892/boris.110517 · Cited by 43 · see citing works
Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects
Azran, C., Porat, D., Fine‐Shamir, N., Hanhan, N., & Dahan, A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.01.001 · Cited by 42 · see citing works
Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli, C., Pirola, I., Gandossi, E., Formenti, A., & Castellano, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0693 · Cited by 41 · see citing works
Novel thyroxine formulations: a further step toward precision medicine
Virili, C., Trimboli, P., & Centanni, M. (2019) · Endocrine · doi:10.1007/s12020-019-02049-x · Cited by 41 · see citing works
Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019) · Drugs in Context · doi:10.7573/dic.212597 · Cited by 40 · see citing works
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism
Stott, D. J., Rodondi, N., & Bauer, D. C. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1709989 · Cited by 48 · see citing works
de Carvalho, G. A., Paz-Filho, G., Mesa, C. O., & Graf, H. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0947 · Cited by 41 · see citing works
Azran, C., Hanhan-Shamshoum, N., Irshied, T., Ben-Shushan, T., Dicker, D., Dahan, A., & Matok, I. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.02.028 · Cited by 40 · see citing works
Ruchała, M., Szczepanek‐Parulska, E., & Zybek, A. (2012) · PubMed · Cited by 38 · see citing works
Treatment-refractory hypothyroidism
Ramadhan, A., & Tamilia, M. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110994 · Cited by 37 · see citing works
Thyroid hormone replacement: current status and challenges
Okosieme, O. E. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.600307 · Cited by 33 · see citing works
Centanni, M., Duntas, L., Feldt-Rasmussen, U., Koehrle, J., Peeters, R. P., Razvi, S., Trimboli, P., & Virili, C. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0123 · Cited by 38 · see citing works
“…dosing resulted in the highest and most variable TSH levels, while a regimen of LT4 being administered an hour before breakfast was associated with the lowest and least variable TSH; the bedtime LT4 regimen produced values and variability that was in-between the other two dosing regimens (41).”
Tanguay, M., Girard, J., Scarsi, C., Mautone, G., & Larouche, R. (2019) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.608 · Cited by 33 · see citing works
Skelin, M., Lucijanić, T., Liberati-Čizmek, A.-M., Klobučar, S. M., Lucijanić, M., Jakupović, L., Bakula, M., Lončar, J. V., Marušić, S., Matić, T., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1686-1 · Cited by 31 · see citing works
Bernareggi, A., Grata, E., Pinorini, M., & Conti, A. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5040621 · Cited by 30 · see citing works
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation
Morelli, S., Reboldi, G., Moretti, S., Menicali, E., Avenia, N., & Puxeddu, E. (2016) · Endocrine · doi:10.1007/s12020-015-0788-2 · Cited by 30 · see citing works
Cappelli, C., Pirola, I., Gandossi, E., Cristiano, A., Daffini, L., Agosti, B., Casella, C., & Castellano, M. (2016) · International Journal of Endocrinology · doi:10.1155/2016/9043450 · Cited by 29 · see citing works
Bornschein, A., Paz-Filho, G., Graf, H., & de Carvalho, G. A. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000400006 · Cited by 28 · see citing works
The clinical utility of free thyroxine in oral levothyroxine absorption testing
Ching Sun, G. E., Pantalone, K. M., Faiman, C., Gupta, M., Olansky, L., & Hatipoglu, B. (2014) · Endocrine Practice · doi:10.4158/ep13487.or · Cited by 27 · see citing works
Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review
Liu, H., Lu, M., Hu, J., Fu, G., Feng, Q., Sun, S., & Chen, C. (2023) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s414460 · Cited by 29 · see citing works
Bagattini, B., Cosmo, C. D., Montanelli, L., Piaggi, P., Ciampi, M., Agretti, P., Marco, G. D., Vitti, P., & Tonacchera, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0621 · Cited by 28 · see citing works
Sheikh, A., Mawani, M., & Mahar, S. A. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0038 · Cited by 26 · see citing works
Update on the treatment of hypothyroidism
Jonklaas, J. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000242 · Cited by 25 · see citing works
The Challenges and Complexities of Thyroid Hormone Replacement
Kansagra, S. M., McCudden, C. R., & Willis, M. S. (2010) · Laboratory Medicine · doi:10.1309/lmb39th2fzgndgim · Cited by 24 · see citing works
Lombardi, C. P., Bocale, R., Barini, A., Barini, A., D’Amore, A., Boscherini, M., & Bellantone, R. (2017) · Endocrine · doi:10.1007/s12020-016-1003-9 · Cited by 23 · see citing works
L-T4 Therapy in Enteric Malabsorptive Disorders
Fallahi, P., Ferrari, S. M., Elia, G., Ragusa, F., Paparo, S. R., & Antonelli, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626371 · Cited by 23 · see citing works
Pirola, I., Gandossi, E., Brancato, D., Marini, F., Cristiano, A., Delbarba, A., Agosti, B., Castellano, M., & Cappelli, C. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0867-3 · Cited by 21 · see citing works
Ucci, S., Renzini, A., Russi, V., Mangialardo, C., Cammarata, I., Cavioli, G., Santaguida, M. G., Virili, C., Centanni, M., Adamo, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225754 · Cited by 21 · see citing works
Guglielmi, V., Bellia, A., Bianchini, E., Medea, G., Cricelli, I., Sbraccia, P., Lauro, D., Cricelli, C. A., & Lapi, F. (2017) · Endocrine · doi:10.1007/s12020-017-1412-4 · Cited by 20 · see citing works
Park, S. H., & Hong, S. H. (2018) · Journal of Medical Internet Research · doi:10.2196/11085 · Cited by 20 · see citing works
Dabbous, Z., Alowainati, B., Darwish, S., Ali, H. A., Farook, S., Malaheem, M. A., Abdalrubb, A., Gul, W., & Haliqa, W. A. (2019) · International Journal of Endocrinology · doi:10.1155/2019/9843961 · Cited by 20 · see citing works
Raza, S., Ishtiaq, O., Unnikrishnan, A., Khan, A. A., Ahmad, J., Ganie, M., Azad, K., Baruah, M. P., & Pathan, M. F. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.98001 · Cited by 18 · see citing works
Does TSH Reliably Detect Hypothyroid Patients?
Soldin, S. J. (2018) · Annals of Thyroid Research · doi:10.26420/annalsthyroidres.2018.1030 · Cited by 18 · see citing works
Vyas, U., Sethi, B. K., & Khandelwal, D. (2018) · Thyroid Research and Practice · doi:10.4103/trp.trp_25_17 · Cited by 23 · see citing works
Ramadan Fasting and Changes in Thyroid Function in Hypothyroidism: Identifying Patients at Risk
Alkaf, B., Siddiqui, M., Ali, T., Bakir, A., Murphy, K. G., Meeran, K. M., & Lessan, N. G. (2022) · Thyroid · doi:10.1089/thy.2021.0512 · Cited by 16 · see citing works
Hypothyroidism and Thyroiditis
Brent, G. A., & Weetman, A. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00013-7 · Cited by 16 · see citing works
Reardon, D. P., & Yoo, P. S. (2016) · Case Reports in Endocrinology · doi:10.1155/2016/1316724 · Cited by 16 · see citing works
Al-Qahtani, K. M., Aldeeri, I. A., Alshaibi, A. M., Alshabib, N. S., Barghouthi, R. M., Alyusuf, E. Y., & Jammah, A. A. (2022) · Thyroid · doi:10.1089/thy.2022.0110 · Cited by 15 · see citing works
Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
Razvi, S., Mrabeti, S., & Luster, M. (2020) · Endocrine Connections · doi:10.1530/ec-20-0205 · Cited by 15 · see citing works
“9 levels, compared with administration in the fasting state [89].”
BackgroundDiagnosis and Management of Iatrogenic Hypothyroidism
Peterson, M. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-22652-3.00023-2 · Cited by 15 · see citing works
Islamic Fasting and Thyroid Hormones
Azizi, F. (2015) · Intern J Endocrinol Metab · doi:10.5812/ijem.13(2)2015.29248 · Cited by 15 · see citing works
Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting
Rdzak, G. M., Whitman, L. M., & Inzucchi, S. E. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818771433 · Cited by 14 · see citing works
Cataldo, E., Columbano, V., Nielsen, L., Gendrot, L., Covella, B., & Piccoli, G. B. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0947-9 · Cited by 14 · see citing works
Tortora, A., La Sala, D., & Vitale, M. (2019) · Endocrinology, Diabetes & Metabolism Case Reports · doi:10.1530/edm-19-0026 · Cited by 13 · see citing works
Controlled delivery of levothyroxine using porous silicon as a drug nanocontainer
Kashanian, S., Rostami, E., Harding, F. J., McInnes, S. J. P., Al-Bataineh, S., & Voelcker, N. H. (2016) · Australian Journal of Chemistry · doi:10.1071/ch15315 · Cited by 13 · see citing works
Ducharme, M., Scarsi, C., Bettazzi, E., Mautone, G., Lewis, Y., & Celi, F. S. (2022) · Thyroid · doi:10.1089/thy.2021.0604 · Cited by 13 · see citing works
Should the dose of levothyroxine be changed in hypothyroidism patients fasting during Ramadan?
Koca, A. O., Dağdeviren, M., & Altay, M. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1911-28 · Cited by 13 · see citing works
Stagi, S., Municchi, G., Ferrari, M., & Wasniewska, M. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.859487 · Cited by 14 · see citing works
Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption
Gatta, E., Bambini, F., Buoso, C., Gava, M., Maltese, V., Anelli, V., Delbarba, A., Pirola, I., & Cappelli, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1080108 · Cited by 13 · see citing works
El-Kaissi, S., Dajani, R. Z., John, T. J. L.-S., Santarina, S. A., Makia, F., AlTakruri, M., & Ahmed, Y. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0505 · Cited by 13 · see citing works
Carbimazole-Induced Acute Pancreatitis and Cholestatic Hepatitis
Chng, C. L., Kek, P. C., Khoo, D. H. C., Granata, A. R. M., Floccari, F., & Gallieni, M. A. (2011) · Endocrine Practice · doi:10.4158/ep.17.6.960 · Cited by 12 · see citing works
Marina, M., Ceda, G. P., Aloe, R., Gnocchi, C., & Ceresini, G. (2016) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 12 · see citing works
Attanasio, R., Žarković, M., Papini, E., Nagy, E. V., Negro, R., Perros, P., Akarsu, E., Alevizaki, M., Ayvaz, G., Bednarczuk, T., et al. (2024) · Thyroid® · doi:10.1089/thy.2023.0580 · Cited by 11 · see citing works
Best Time for Levothyroxine Intake in Ramadan (THYRAM): Basrah Experience
Zaboon, I. A., Alidrisi, H. A., Hussein, I. H., Alabbood, M., Alibrahim, N. T. Y., Almomin, A., Al-Waeli, D. K., Alhamza, A. H. A., Mohammed, A. G., Nwayyir, H. A., et al. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.94325 · Cited by 11 · see citing works
Dose administration time from before breakfast to before dinner affect thyroid hormone levels?
Ala, S., Akha, O., Kashi, Z., Asgari, H., Bahar, A., & Sasanpour, N. (2015) · PubMed Central · Cited by 11 · see citing works
Lewandowski, K. C., Dąbrowska, K., Komorowska-Dudek, I., & Lewiński, A. (2015) · Thyroid Research · doi:10.1186/s13044-015-0028-0 · Cited by 10 · see citing works
- Authors
- Bach-Huynh, T.-G., Nayak, B., Loh, J., Soldin, S., & Jonklaas, J.
- Affiliations
- Georgetown University Medical Center (US)
- Corresponding author
- Jonklaas, Jacqueline
- ORCID
- Jonklaas, Jacqueline
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-10-01
- Volume
- 94
- Issue
- 10
- Pages
- 3905-3912
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2758731
- OpenAlex
- W2110073453
- Cited by
- 198
- References
- 30
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 10 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 11 · 2019: 11 · 2018: 19 · 2017: 10 · 2016: 21 · 2015: 16 · 2014: 12 · 2013: 11 · 2012: 14
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Center for Research Resources (K23 RR16524, M01RR020359, MO1-RR-020359, K23RR016524)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- levothyroxine, timing of drug administration, serum thyrotropin, thyroid-stimulating hormone, dietary intake, fasting, hypothyroidism, thyroid cancer, free thyroxine, total T3, drug absorption
- MeSH terms
- Administration, Oral, Adult, Aged, Drug Administration Schedule, Fasting, Female, Humans, Hypothyroidism, Male, Middle Aged, Thyroid Hormones, Thyroid Neoplasms, Thyrotropin, Thyroxine, Time Factors, Cross-Over Studies, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review